American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 Growth ETF
IWF
|
+$510M |
| 2 |
ExxonMobil
XOM
|
+$222M |
| 3 |
Apple
AAPL
|
+$199M |
| 4 |
CRH
CRH
|
+$189M |
| 5 |
Meta Platforms (Facebook)
META
|
+$183M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$387M |
| 2 |
Colgate-Palmolive
CL
|
+$242M |
| 3 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$235M |
| 4 |
Starbucks
SBUX
|
+$183M |
| 5 |
Equinix
EQIX
|
+$168M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.37% |
| 2 | Financials | 12.82% |
| 3 | Healthcare | 11.59% |
| 4 | Consumer Discretionary | 11.43% |
| 5 | Industrials | 9.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VTYX
2776
DELISTED
Ventyx Biosciences
VTYX
| $59.8K | ﹤0.01% |
+25,883
| New | +$108K |
|
|
LAR
2777
Lithium Argentina AG
LAR
$1.13B
| $59.5K | ﹤0.01% |
18,680
| – | – |
|
2778
BioAtla
BCAB
$5.56M
| $59.4K | ﹤0.01% |
868
+230
| +36% | +$27.4K |
|
2779
Frontier Group Holdings
ULCC
$1.59B
| $57.7K | ﹤0.01% |
11,713
-68,435
| -85% | -$410K |
|
2780
Arbutus Biopharma
ABUS
$908M
| $57.1K | ﹤0.01% |
18,486
-107,728
| -85% | -$323K |
|
|
GAU
2781
Galiano Gold
GAU
$544M
| $54.5K | ﹤0.01% |
31,701
| – | – |
|
2782
1stdibs.com
DIBS
$161M
| $54.4K | ﹤0.01% |
+12,119
| New | +$66.2K |
|
2783
KVH Industries
KVHI
$146M
| $53.9K | ﹤0.01% |
+11,600
| New | +$57.9K |
|
2784
GSI Technology
GSIT
$259M
| $52.5K | ﹤0.01% |
19,827
+5,890
| +42% | +$19.2K |
|
2785
Oramed Pharmaceuticals
ORMP
$184M
| $50.3K | ﹤0.01% |
19,591
| – | – |
|
|
ESPR
2786
DELISTED
Esperion Therapeutics
ESPR
| $50K | ﹤0.01% |
+22,518
| New | +$53K |
|
|
TUYA
2787
Tuya Inc
TUYA
$1.08B
| $49.9K | ﹤0.01% |
29,178
| – | – |
|
|
AIFU
2788
AIFU Inc
AIFU
$219M
| $46.7K | ﹤0.01% |
59
-3
| -5% | -$4.03K |
|
|
AMTD
2789
AMTD IDEA Group
AMTD
$70.2M
| $44.1K | ﹤0.01% |
26,417
| – | – |
|
|
OPTU
2790
Optimum Communications Inc
OPTU
$229M
| $44K | ﹤0.01% |
21,561
-563
| -3% | -$1.25K |
|
|
MAGN
2791
Magnera Corp
MAGN
$434M
| $42.9K | ﹤0.01% |
2,375
+259
| +12% | +$5.58K |
|
|
AEVA
2792
Aeva Technologies
AEVA
$1.68B
| $38.5K | ﹤0.01% |
+15,264
| New | +$49.8K |
|
|
ACCD
2793
DELISTED
Accolade Inc
ACCD
| $37.4K | ﹤0.01% |
10,451
-1,471
| -12% | -$11.1K |
|
|
OMGA
2794
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
| $37.4K | ﹤0.01% |
18,048
-7,267
| -29% | -$17.1K |
|
2795
Amylyx Pharmaceuticals
AMLX
$2.56B
| $36.2K | ﹤0.01% |
19,041
-359,757
| -95% | -$697K |
|
2796
Crexendo
CXDO
$216M
| $36K | ﹤0.01% |
11,458
+500
| +5% | +$1.95K |
|
2797
China Automotive Systems
CAAS
$145M
| $35.7K | ﹤0.01% |
+10,059
| New | +$37K |
|
2798
Corvus Pharmaceuticals
CRVS
$1.26B
| $33.2K | ﹤0.01% |
18,248
| – | – |
|
|
FRGE
2799
DELISTED
Forge Global Holdings
FRGE
| $28.3K | ﹤0.01% |
1,292
-4,892
| -79% | -$130K |
|
|
NIU
2800
Niu Technologies
NIU
$168M
| $27.8K | ﹤0.01% |
15,966
+740
| +5% | +$1.52K |
|
Similar funds
American Century Companies's Q2 2024 Portfolio in Review
As of Q2 2024, American Century Companies held 3,009 positions worth $163B, up 2.7% from $159B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
American Century Companies's Q2 2024 filing shows 89 new, 1,863 increased, 760 reduced and 131 closed positions. Its largest new stake was UL Solutions: 1,631,475 shares worth $68.8M. The largest sale was UnitedHealth, an estimated $387M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Financials and Healthcare.
- American Century Companies's largest Q2 2024 buy was UL Solutions: 1,631,475 shares worth $68.8M.
- American Century Companies added most to iShares Russell 1000 Growth ETF in Q2 2024, an estimated $510M increase.
- American Century Companies's biggest Q2 2024 reduction was UnitedHealth, cutting an estimated $387M.
- American Century Companies fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $235M.
- American Century Companies's ten largest holdings make up 27% of its $163B portfolio in Q2 2024.
- American Century Companies opened 89 new positions and closed 131 in Q2 2024.
- American Century Companies's portfolio value rose 2.7% quarter-over-quarter to $163B.
Based on American Century Companies's 13F filing for Q2 2024, filed 7 Aug 2024.